BIIB vs ROK · P/E 21, rev $9.89B vs P/E 48, rev $8.34B
Biogen Inc (BIIB) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the BIIB and ROK stock pages for the full models.
Not investment advice.